The increasing capabilities of computing have changed biology from a realm dominated by scientific discovery to one that intersects with engineering and innovation. Vijay Pande, a General Partner at Andreessen Horowitz, joins Azeem Azhar to discuss the emergence of this novel industry at the interface of technology and biology. They also discuss: The most promising technologies to combat Covid-19 that are being tested. Why next-gen biotech companies look increasingly like tech startups. Why our long-term health depends on regulators and society engaging with this tech. Further reading: “The Next Trillion Dollar Market” (Exponential View podcast, 2020) “Drug Discovery in the Age of Coronavirus” (Vijay Pande, 2020) @VijayPande @Azeem @exponentialview Exponential View newsletter SUPPORT US! If you love what we do, please take a moment to vote for us: British Podcast Awards, Listener’s Choice. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from Azeem Azhar's Exponential View
Transcribed and ready to explore now
The method of invention, AI's new clock speed and why capital markets are confused
05 Dec 2025
Azeem Azhar's Exponential View
Why the AI productivity gains haven’t arrived - yet
21 Nov 2025
Azeem Azhar's Exponential View
Where did all the entry-level jobs go? (With Revelio CEO Ben Zweig)
14 Nov 2025
Azeem Azhar's Exponential View
The demand for infinite compute
07 Nov 2025
Azeem Azhar's Exponential View
Inside the US–China decoupling: What’s really at stake (AI, rare earths, Taiwan, trade)
23 Oct 2025
Azeem Azhar's Exponential View
Inside the collapse of the internet economy (and what comes next)
08 Oct 2025
Azeem Azhar's Exponential View